Manufacturer record

Regent Ajanta Biotech: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

6 batches manufactured by Regent Ajanta Biotech (Uttarakhand) were declared Not of Standard Quality between January 2025 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

6 records linked to Regent Ajanta Biotech in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
6Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Jan 2025 to Jun 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

6
NSQ batches since 2025
6
Products affected
Assay
Most common failure
Jun 2026
Latest alert

Flagged batches per year

2025 · 32026 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Telmisartan 40mg & Amlodipine Besylate Tablets IP 5mg PRT2512-47Mfg 2025-12 · Exp 2027-11 The sample does not conform to I.P. w.r.to the tests for DissolutionDissolution SDTL, GuwahatiState lab Jun 2026
Levocetirizine Dihydrochloride Tablets IP 5mg PRT2501-149Mfg 2025-01 · Exp 2026-12 The sample does not conform to standard quality in respect of the test for Description performed.Description SDTL, Tripura, AgartalaState lab Jun 2026
Paracetamol, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Suspension125mg/5mg/1mg (60ml) PRL2501-03Mfg 2025-01 · Exp 2026-12 The sample received does not conform to Manufacturers specification with respect to the test for Description and Assay of Phenyleprhine hydrochloride.Assay CDTL, MumbaiCDSCO lab Apr 2026
Sucralfate & Oxetacaine Oral Suspension(Sucrakars- O Suspension) RL2412-10Mfg 2024-12 · Exp 2026-11 Assay of SucralfateAssay CDL, KolkataCDSCO lab Jul 2025
Luliconazole Cream IP 1% w/w 2946Mfg 2024-05 · Exp 2026-04 sample does not Conform to IP Specification for Luliconazole Cream with respect to the PH of 10% w/v solution.pH DTL MaduraiState lab Jan 2025
Aceclofenac & Drotaverine Hydrochlori de Tablets (100 mg/ 80 mg) PRT2401 -01Mfg 2024-01 · Exp 2025-12 DescriptionDescription State Lab KarnatakaState lab Jan 2025

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.